Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status

INTRODUCTION: Few studies have examined memory decline among patients with type 2 diabetes using different oral hypoglycemic drugs. METHODS: Participants with normal cognition (NC) or Alzheimer's disease (AD) dementia using a hypoglycemic medication (2005 to 2019) were identified from the Natio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Che‐Yuan, Ouk, Michael, Wong, Yuen Yan, Anita, Natasha Z., Edwards, Jodi D., Yang, Pearl, Shah, Baiju R., Herrmann, Nathan, Lanctôt, Krista L., Kapral, Moira K., MacIntosh, Bradley J., Rabin, Jennifer S., Black, Sandra E., Swardfager, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754496/
https://www.ncbi.nlm.nih.gov/pubmed/32803865
http://dx.doi.org/10.1002/alz.12161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754496/
https://www.ncbi.nlm.nih.gov/pubmed/32803865
http://dx.doi.org/10.1002/alz.12161

Ejemplares similares